on 28 Feb 2024
Last Applicant/ Owned by
20 Acorn Park Drive, Tower 500
Cambridge
MA
02140
Serial Number
97365239 filed on 15th Apr 2022
Registration Number
N/A
Correspondent Address
CHRISTINA M. LICURSI
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of Read More
Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy
N/A
N/A
Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use
N/A
N/A
Manufacturing of pharmaceuticals, gene therapy products, and cell therapy products for others
N/A
N/A
No 97365239
No Service Mark
No A12652000200
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
20th Dec 2024 | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF |
04th Nov 2024 | ASSIGNED TO EXAMINER |
28th Feb 2024 | EX PARTE APPEAL-INSTITUTED |
28th Feb 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
27th Nov 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
27th Nov 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
31st Aug 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
31st Aug 2023 | FINAL REFUSAL E-MAILED |
31st Aug 2023 | FINAL REFUSAL WRITTEN |
04th Aug 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |